Long-term prophylaxis with Lanadelumab led to a significant reduction in attack frequency and severity, improving his quality of life (Figure 1 shows the QoL questionnaire results)
Who Might Consider Oral Options Oral kits might make sense for women who are not comfortable with self-injection, who may not meet eligibility criteria for GLP-1 medications, who want a lower-cost starting point, or whose clinician determines oral medications are more appropriate based on their health history
Foods with a high level of histamine tend to be processed, preserved, or pickled
PMID: 9879640 | doi:10.1080/004982598238976 Hansen TK et al
Why three receptors outperform one Think of it this way
GLP-1 RAs = glucagon-like peptide-1 receptor agonists GLP-1/GIPRAs = dual glucagon-like peptide-1 / glucose-dependent insulinotrophic peptide receptor co-agonists ANZCAs latest clinical practice recommendations were updated and released in April 2025 here are the key changes you need to know
